The results provided herein therefore support the possibility that the e-sEV-mediated activation of the TGFβ1/ALK1/ID1 cascade may provide a fine tuning angiogenic response which balances the vascular remodeling process and protects muscles against ischemia-induced damage. The gene discussed is TGFB1; the disease is ischemia.